# Knott David M

> Institutional holdings reported to the SEC as of Q3 2021 on Form 13F. CIK 808722. Source: https://holderbook.com/funds/808722-knott-david-m/

- Reported value: $275.2M
- Positions: 150
- Weight of the ten largest: 46.5%
- Filed: 2021-11-12

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| CALUMET SPECIALTY PRODS PART | [CLMTXXXX](https://holderbook.com/stocks/CLMTXXXX/) | $28.2M | 3,567,500 | 10.3% | 12 |
| APOLLO GLOBAL MGMT INC | [APOXXXX](https://holderbook.com/stocks/APOXXXX/) | $15.4M | 250,000 | 5.6% | 9 |
| ALPHABET INC | [GOOG](https://holderbook.com/stocks/GOOG/) | $14.9M | 5,600 | 5.4% | 11 |
| FORTRESS TRANS INFRST INVS L | [FTAIXXXX](https://holderbook.com/stocks/FTAIXXXX/) | $12.6M | 497,700 | 4.6% | 6 |
| GREENIDGE GENERATION HLDGS I | [GREEL](https://holderbook.com/stocks/GREEL/) | $11.5M | 0 | 4.2% | 1 |
| LIGAND PHARMACEUTICALS INC | [LGND](https://holderbook.com/stocks/LGND/) | $10.4M | 75,000 | 3.8% | 12 |
| UPLAND SOFTWARE INC | [UPLD](https://holderbook.com/stocks/UPLD/) | $10.0M | 300,000 | 3.6% | 12 |
| COLISEUM ACQUISITION CORP | [MITA](https://holderbook.com/stocks/MITA/) | $9.6M | 984,835 | 3.5% | 1 |
| KADMON HLDGS INC | [KDMN](https://holderbook.com/stocks/KDMN/) | $8.6M | 989,450 | 3.1% | 9 |
| MIDWEST HLDG INC | [MDWT](https://holderbook.com/stocks/MDWT/) | $6.6M | 170,000 | 2.4% | 5 |
| GREENIDGE GENERATION HLDGS I | [GREE](https://holderbook.com/stocks/GREE/) | $5.7M | 224,000 | 2.1% | 1 |
| COLISEUM ACQUISITION CORP | [MITAW](https://holderbook.com/stocks/MITAW/) | $5.7M | 495,000 | 2.1% | 1 |
| AFRICAN GOLD ACQUISITION COR | [AGACWS](https://holderbook.com/stocks/AGACWS/) | $5.3M | 463,500 | 1.9% | 2 |
| TWELVE SEAS INVESTMENT CO II | [TWLV](https://holderbook.com/stocks/TWLV/) | $5.0M | 515,000 | 1.8% | 2 |
| PFIZER INC | [PFE](https://holderbook.com/stocks/PFE/) | $4.9M | 114,500 | 1.8% | 12 |
| GLASS HOUSES ACQUISITION COR | [GLHA](https://holderbook.com/stocks/GLHA/) | $4.9M | 500,000 | 1.8% | 2 |
| FS KKR CAP CORP | [FSK](https://holderbook.com/stocks/FSK/) | $4.4M | 199,825 | 1.6% | 4 |
| KENNEDY-WILSON HOLDINGS INC | [KW](https://holderbook.com/stocks/KW/) | $4.4M | 210,000 | 1.6% | 6 |
| EASTERN BANKSHARES INC | [EBC](https://holderbook.com/stocks/EBC/) | $3.9M | 190,000 | 1.4% | 4 |
| REGENERON PHARMACEUTICALS | [REGN](https://holderbook.com/stocks/REGN/) | $3.6M | 6,000 | 1.3% | 2 |
| TRILLIUM THERAPEUTICS INC | - | $3.5M | 198,699 | 1.3% | 7 |
| LIVE OAK MOBILITY ACQUISI CO | [LOKM](https://holderbook.com/stocks/LOKM/) | $3.5M | 360,152 | 1.3% | 2 |
| B RILEY PRIN 250 MERGER CORP | [BRIV](https://holderbook.com/stocks/BRIV/) | $3.4M | 350,000 | 1.2% | 1 |
| KAIROS ACQUISITION CORP | [KAIR](https://holderbook.com/stocks/KAIR/) | $3.3M | 345,463 | 1.2% | 3 |
| DANIMER SCIENTIFIC INC | [DNMRXXXX](https://holderbook.com/stocks/DNMRXXXX/) | $3.3M | 200,000 | 1.2% | 4 |
| KKR & CO INC | [KKR](https://holderbook.com/stocks/KKR/) | $3.0M | 50,000 | 1.1% | 7 |
| AVADEL PHARMACEUTICALS PLC | [AVDLXXXX](https://holderbook.com/stocks/AVDLXXXX/) | $3.0M | 301,864 | 1.1% | 4 |
| GLASS HOUSES ACQUISITION COR | [GLHAW](https://holderbook.com/stocks/GLHAW/) | $2.9M | 250,000 | 1.0% | 2 |
| UNITED THERAPEUTICS CORP DEL | [UTHR](https://holderbook.com/stocks/UTHR/) | $2.8M | 15,300 | 1.0% | 3 |
| JPMORGAN CHASE & CO | [JPM](https://holderbook.com/stocks/JPM/) | $2.7M | 16,740 | 1.0% | 12 |
| BRISTOL-MYERS SQUIBB CO | [BMY](https://holderbook.com/stocks/BMY/) | $2.5M | 42,409 | 0.9% | 12 |
| ALLIANCEBERNSTEIN HLDG L P | [AB](https://holderbook.com/stocks/AB/) | $2.5M | 50,500 | 0.9% | 12 |
| HORIZON THERAPEUTICS PUB L | [HZNP](https://holderbook.com/stocks/HZNP/) | $2.2M | 20,000 | 0.8% | 9 |
| HORIZON ACQUISITION CORP | [HZAC](https://holderbook.com/stocks/HZAC/) | $2.1M | 210,100 | 0.8% | 1 |
| EIGER BIOPHARMACEUTICALS INC | [EIGR](https://holderbook.com/stocks/EIGR/) | $2.1M | 312,492 | 0.8% | 12 |
| TWELVE SEAS INVESTMENT CO II | [TWLVW](https://holderbook.com/stocks/TWLVW/) | $2.0M | 171,666 | 0.7% | 2 |
| TASTEMAKER ACQUISITION CORP | [PMGM](https://holderbook.com/stocks/PMGM/) | $2.0M | 200,000 | 0.7% | 3 |
| MEDICUS SCIENCES ACQUISITION | [MSAC](https://holderbook.com/stocks/MSAC/) | $1.9M | 200,000 | 0.7% | 1 |
| INNOVIVA INC | [INVA](https://holderbook.com/stocks/INVA/) | $1.9M | 115,269 | 0.7% | 2 |
| ZOGENIX INC | [ZGNX](https://holderbook.com/stocks/ZGNX/) | $1.9M | 124,688 | 0.7% | 7 |
| INCYTE CORP | [INCY](https://holderbook.com/stocks/INCY/) | $1.8M | 26,475 | 0.7% | 1 |
| B RILEY PRINCIPAL 150 MERGER | [BRPM](https://holderbook.com/stocks/BRPM/) | $1.7M | 176,963 | 0.6% | 2 |
| KAIROS ACQUISITION CORP | [KAIRW](https://holderbook.com/stocks/KAIRW/) | $1.7M | 146,528 | 0.6% | 3 |
| TG THERAPEUTICS INC | [TGTX](https://holderbook.com/stocks/TGTX/) | $1.6M | 49,592 | 0.6% | 6 |
| COHERUS ONCOLOGY INC | [CHRS](https://holderbook.com/stocks/CHRS/) | $1.6M | 102,555 | 0.6% | 12 |
| UNIQURE NV | [QURE](https://holderbook.com/stocks/QURE/) | $1.5M | 46,766 | 0.5% | 8 |
| XENON PHARMACEUTICALS INC | [XENE](https://holderbook.com/stocks/XENE/) | $1.4M | 94,488 | 0.5% | 12 |
| AURINIA PHARMACEUTICALS INC | [AUPH](https://holderbook.com/stocks/AUPH/) | $1.4M | 62,896 | 0.5% | 7 |
| B RILEY PRIN 250 MERGER CORP | [BRIVW](https://holderbook.com/stocks/BRIVW/) | $1.3M | 116,666 | 0.5% | 1 |
| VIKING THERAPEUTICS INC | [VKTX](https://holderbook.com/stocks/VKTX/) | $1.3M | 208,102 | 0.5% | 12 |
| TASTEMAKER ACQUISITION CORP | [PMGMW](https://holderbook.com/stocks/PMGMW/) | $1.1M | 100,000 | 0.4% | 3 |
| GILEAD SCIENCES INC | [GILD](https://holderbook.com/stocks/GILD/) | $1.1M | 15,481 | 0.4% | 5 |
| RYMAN HOSPITALITY PPTYS INC | [RHP](https://holderbook.com/stocks/RHP/) | $1.0M | 12,400 | 0.4% | 12 |
| ROTH CH ACQUISITION III CO | [ROCR](https://holderbook.com/stocks/ROCR/) | $994.0K | 100,000 | 0.4% | 2 |
| VERIZON COMMUNICATIONS INC | [VZ](https://holderbook.com/stocks/VZ/) | $972.0K | 17,991 | 0.4% | 12 |
| DOMA HOLDINGS INC | [DOMAW](https://holderbook.com/stocks/DOMAW/) | $958.0K | 83,333 | 0.3% | 1 |
| MONDELEZ INTL INC | [MDLZ](https://holderbook.com/stocks/MDLZ/) | $931.0K | 16,000 | 0.3% | 12 |
| CIDARA THERAPEUTICS INC COM NEW | [CDTXXXXX](https://holderbook.com/stocks/CDTXXXXX/) | $930.0K | 415,308 | 0.3% | 10 |
| MARINUS PHARMACEUTICALS INC | [MRNS](https://holderbook.com/stocks/MRNS/) | $924.0K | 81,166 | 0.3% | 4 |
| ABBVIE INC | [ABBV](https://holderbook.com/stocks/ABBV/) | $863.0K | 8,000 | 0.3% | 12 |
| ASLAN PHARMACEUTICALS LTD | [ASLN](https://holderbook.com/stocks/ASLN/) | $851.0K | 478,186 | 0.3% | 3 |
| JOHNSON & JOHNSON | [JNJ](https://holderbook.com/stocks/JNJ/) | $840.0K | 5,200 | 0.3% | 12 |
| LIVE OAK MOBILITY ACQUISI CO | [LOKMWS](https://holderbook.com/stocks/LOKMWS/) | $828.0K | 72,030 | 0.3% | 2 |
| DUPONT DE NEMOURS INC | [DD](https://holderbook.com/stocks/DD/) | $826.0K | 12,160 | 0.3% | 10 |
| KIMBERLY-CLARK CORP | [KMB](https://holderbook.com/stocks/KMB/) | $795.0K | 6,000 | 0.3% | 12 |
| COLOMBIER ACQUISITION CORP | [CLBR](https://holderbook.com/stocks/CLBR/) | $774.0K | 80,000 | 0.3% | 1 |
| QUOTIENT TECHNOLOGY INC | [QUOT](https://holderbook.com/stocks/QUOT/) | $728.0K | 125,000 | 0.3% | 4 |
| COCA COLA CO | [KO](https://holderbook.com/stocks/KO/) | $703.0K | 13,400 | 0.3% | 12 |
| DOW HLDGS INC | [DOW](https://holderbook.com/stocks/DOW/) | $700.0K | 12,160 | 0.3% | 10 |
| CANADIAN NAT RES LTD MED TER | [CNQ](https://holderbook.com/stocks/CNQ/) | $690.0K | 18,885 | 0.3% | 12 |
| B RILEY PRINCIPAL 150 MERGER | [BRPMW](https://holderbook.com/stocks/BRPMW/) | $678.0K | 58,986 | 0.2% | 2 |
| LONGVIEW ACQUISITION CORP II | [LGV](https://holderbook.com/stocks/LGV/) | $632.0K | 63,900 | 0.2% | 2 |
| AT&T INC | [T](https://holderbook.com/stocks/T/) | $543.0K | 20,125 | 0.2% | 12 |
| Macquire Infrastructure Corp | - | $542.0K | 13,350 | 0.2% | 1 |
| CORTEVA INC | [CTVA](https://holderbook.com/stocks/CTVA/) | $508.0K | 12,075 | 0.2% | 10 |
| BUTTERFLY NETWORK INC | [BFLY](https://holderbook.com/stocks/BFLY/) | $478.0K | 45,760 | 0.2% | 3 |
| WP CAREY INC | [WPC](https://holderbook.com/stocks/WPC/) | $438.0K | 6,000 | 0.2% | 12 |
| MICROSOFT CORP | [MSFT](https://holderbook.com/stocks/MSFT/) | $395.0K | 1,400 | 0.1% | 12 |
| IMMUNOVANT INC | [IMVT](https://holderbook.com/stocks/IMVT/) | $370.0K | 42,600 | 0.1% | 3 |
| GLOBUS MED INC | [GMED](https://holderbook.com/stocks/GMED/) | $355.0K | 4,631 | 0.1% | 11 |
| IBERE PHARMACEUTICALS | [IBER](https://holderbook.com/stocks/IBER/) | $349.0K | 36,000 | 0.1% | 2 |
| CONAGRA BRANDS INC | [CAG](https://holderbook.com/stocks/CAG/) | $339.0K | 10,000 | 0.1% | 12 |
| META PLATFORMS INC | [META](https://holderbook.com/stocks/META/) | $336.0K | 990 | 0.1% | 3 |
| COLOMBIER ACQUISITION CORP | [CLBRWS](https://holderbook.com/stocks/CLBRWS/) | $307.0K | 26,666 | 0.1% | 1 |
| APPLE INC | [AAPL](https://holderbook.com/stocks/AAPL/) | $297.0K | 2,100 | 0.1% | 12 |
| ROTH CH ACQUISITION III CO | [ROCRW](https://holderbook.com/stocks/ROCRW/) | $288.0K | 25,000 | 0.1% | 2 |
| BRIGHTSTAR LOTTERY PLC | [BRSL](https://holderbook.com/stocks/BRSL/) | $276.0K | 10,500 | 0.1% | 11 |
| MEDICUS SCIENCES ACQUISITION | [MSACW](https://holderbook.com/stocks/MSACW/) | $256.0K | 22,222 | 0.1% | 2 |
| FS BANCORP INC | [FSBW](https://holderbook.com/stocks/FSBW/) | $253.0K | 7,300 | 0.1% | 12 |
| PROTARA THERAPEUTICS INC | [TARA](https://holderbook.com/stocks/TARA/) | $252.0K | 36,479 | 0.1% | 6 |
| WARRIOR TECHNOLOGIES ACQUI C | [WARR](https://holderbook.com/stocks/WARR/) | $245.0K | 25,000 | 0.1% | 2 |
| ALX Oncology Holdings Inc | - | $236.0K | 3,200 | 0.1% | 3 |
| CODEXIS INC | [CDXS](https://holderbook.com/stocks/CDXS/) | $233.0K | 10,000 | 0.1% | 1 |
| CRISPR THERAPEUTICS AG | [CRSP](https://holderbook.com/stocks/CRSP/) | $224.0K | 2,000 | 0.1% | 2 |
| POSEIDA THERAPEUTICS INC | [PSTX](https://holderbook.com/stocks/PSTX/) | $216.0K | 29,566 | 0.1% | 3 |
| IBERE PHARMACEUTICALS | [IBERWS](https://holderbook.com/stocks/IBERWS/) | $207.0K | 18,000 | 0.1% | 2 |
| JUMIA TECHNOLOGIES AG | [JMIA](https://holderbook.com/stocks/JMIA/) | $182.0K | 9,800 | 0.1% | 3 |
| CTI BIOPHARMA CORP | [CTIC](https://holderbook.com/stocks/CTIC/) | $177.0K | 60,000 | 0.1% | 4 |
| AFRICAN GOLD ACQUISITION COR | [AGAC](https://holderbook.com/stocks/AGAC/) | $175.0K | 18,000 | 0.1% | 2 |
| SEELOS THERAPEUTICS INC | [SEEL](https://holderbook.com/stocks/SEEL/) | $174.0K | 72,367 | 0.1% | 3 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q3 2021 | +0.5% | +0.3% | +0.2% | 97% |
| Q2 2021 | +3.3% | +8.0% | -4.7% | 98% |
| Q1 2021 | +17.3% | +6.0% | +11.3% | 99% |
| Q4 2020 | +16.7% | +11.6% | +5.1% | 95% |
| Q3 2020 | -0.9% | +8.6% | -9.5% | 100% |
| Q2 2020 | +33.4% | +19.6% | +13.7% | 89% |
| Q1 2020 | -33.8% | -19.9% | -13.9% | 94% |
| Q4 2019 | +13.9% | +8.5% | +5.5% | 95% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q3 2021 | $275.2M | 150 |
| Q2 2021 | $281.3M | 147 |
| Q1 2021 | $233.8M | 129 |
| Q4 2020 | $221.0M | 110 |
| Q3 2020 | $170.4M | 98 |
| Q2 2020 | $183.2M | 92 |
| Q1 2020 | $158.5M | 121 |
| Q4 2019 | $246.7M | 114 |
| Q3 2019 | $238.0M | 119 |
| Q2 2019 | $237.1M | 111 |
| Q1 2019 | $250.9M | 110 |
| Q4 2018 | $212.8M | 101 |